• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃和十二指肠胃泌素瘤中频繁的 GNAS 和 KRAS 突变。

Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.

机构信息

Pathology and Clinical Laboratories, National Cancer Centre Hospital, Tokyo, Japan.

出版信息

J Pathol. 2013 Mar;229(4):579-87. doi: 10.1002/path.4153. Epub 2013 Feb 4.

DOI:10.1002/path.4153
PMID:23208952
Abstract

Gastric and duodenal adenomas exhibit a significant morphological and phenotypical diversity and are classified into intestinal-type, foveolar-type and pyloric gland adenomas. We analysed the mutations in GNAS, KRAS, BRAF and CTNNB1 and the expressions of mismatch repair (MMR) proteins in 80 gastric and 32 duodenal adenomas with histologically distinct subtypes, as well as in 71 gastric adenocarcinomas. Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas. Fourteen PGAs (41%), two foveolar-type adenomas (9%), five intestinal-type adenomas (9%) and one adenocarcinoma (1%) had KRAS mutations. BRAF mutations were absent in all the adenomas and adenocarcinomas that were examined. CTNNB1 mutations were only found in two intestinal-type adenomas (4%). Notably, 13 of the 14 KRAS-mutated gastric and duodenal PGAs had concurrent GNAS mutations. The loss of the MMR proteins, which is indicative of microsatellite instability, was observed in one PGA (3%), 12 foveolar-type adenomas (52%), one intestinal-type adenoma (2%) and five adenocarcinomas (7%). These observations indicate that each histological subtype of gastric and duodenal adenomas has a distinct genetic background. In particular, the present study identified the frequent presence of activating GNAS mutations, which are often associated with KRAS mutations, as a characteristic genetic feature of PGAs of the stomach and duodenum.

摘要

胃和十二指肠腺瘤表现出显著的形态和表型多样性,并被分为肠型、滤泡型和幽门腺腺瘤。我们分析了 80 例胃和 32 例十二指肠具有不同组织学亚型的腺瘤以及 71 例胃腺癌中 GNAS、KRAS、BRAF 和 CTNNB1 的突变以及错配修复(MMR)蛋白的表达。在 35 例幽门腺腺瘤(PGA;63%)中发现了激活的 GNAS 突变,但在滤泡型或肠型腺瘤或腺癌中均未发现。14 例 PGA(41%)、2 例滤泡型腺瘤(9%)、5 例肠型腺瘤(9%)和 1 例腺癌(1%)有 KRAS 突变。在所有被检测的腺瘤和腺癌中均未发现 BRAF 突变。CTNNB1 突变仅在 2 例肠型腺瘤(4%)中发现。值得注意的是,在 14 例 KRAS 突变的胃和十二指肠 PGA 中,有 13 例同时存在 GNAS 突变。在 1 例 PGA(3%)、12 例滤泡型腺瘤(52%)、1 例肠型腺瘤(2%)和 5 例腺癌(7%)中观察到 MMR 蛋白缺失,表明微卫星不稳定。这些观察结果表明,胃和十二指肠腺瘤的每种组织学亚型都具有独特的遗传背景。特别是,本研究确定了激活的 GNAS 突变的频繁存在,其通常与 KRAS 突变相关,是胃和十二指肠 PGA 的特征性遗传特征。

相似文献

1
Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.胃和十二指肠胃泌素瘤中频繁的 GNAS 和 KRAS 突变。
J Pathol. 2013 Mar;229(4):579-87. doi: 10.1002/path.4153. Epub 2013 Feb 4.
2
Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.胃小凹化生、胃异位及十二指肠腺癌中的GNAS和KRAS激活突变。
Br J Cancer. 2015 Apr 14;112(8):1398-404. doi: 10.1038/bjc.2015.104. Epub 2015 Mar 24.
3
Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features.家族性腺瘤性息肉病相关的和散发性的上消化道幽门腺腺瘤具有共同的遗传特征。
Histopathology. 2015 Nov;67(5):689-98. doi: 10.1111/his.12705. Epub 2015 May 14.
4
Frequent activating GNAS mutations in villous adenoma of the colorectum.结直肠绒毛状腺瘤中频繁出现的激活型 GNAS 突变。
J Pathol. 2012 Sep;228(1):113-8. doi: 10.1002/path.4012. Epub 2012 Jul 2.
5
Morphology and genetics of pyloric gland adenomas in familial adenomatous polyposis.家族性腺瘤性息肉病中幽门腺腺瘤的形态学与遗传学
Histopathology. 2017 Mar;70(4):549-557. doi: 10.1111/his.13105. Epub 2016 Dec 13.
6
Duodenal Neoplasms of Gastric Phenotype: An Immunohistochemical and Genetic Study With a Practical Approach to the Classification.胃表型十二指肠肿瘤:一种免疫组织化学和遗传学研究及分类的实用方法。
Am J Surg Pathol. 2017 Mar;41(3):343-353. doi: 10.1097/PAS.0000000000000785.
7
Serrated adenoma of the stomach: a clinicopathologic, immunohistochemical, and molecular study of nine cases.胃锯齿状腺瘤:九例临床病理、免疫组化和分子研究。
Histol Histopathol. 2013 Apr;28(4):453-62. doi: 10.14670/HH-28.453. Epub 2013 Feb 13.
8
Pyloric gland adenoma in Lynch syndrome.林奇综合征中的幽门腺腺瘤。
Am J Surg Pathol. 2014 Jun;38(6):784-92. doi: 10.1097/PAS.0000000000000185.
9
[Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].[结直肠癌前病变及腺癌中的免疫表型与基因突变]
Zhonghua Bing Li Xue Za Zhi. 2013 Oct;42(10):655-9.
10
Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas.RAS/RAF/丝裂原活化蛋白激酶(MAP)激酶信号通路的突变在胆囊腺瘤中普遍存在,但在胆囊腺癌中并不常见。
Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):133-40. doi: 10.1097/PAI.0b013e3181f09179.

引用本文的文献

1
Clinicopathological and Endoscopic Features of Non-Ampullary Duodenal Epithelial Tumors with Gastrointestinal Mixed Phenotype.具有胃肠道混合表型的非壶腹十二指肠上皮肿瘤的临床病理及内镜特征
Digestion. 2025 Jun 20:1-11. doi: 10.1159/000547024.
2
Long-term survival outcomes of duodenal adenocarcinoma: A cohort study with 15-year single-center experience.十二指肠腺癌的长期生存结果:一项具有15年单中心经验的队列研究。
World J Gastrointest Surg. 2025 Feb 27;17(2):101365. doi: 10.4240/wjgs.v17.i2.101365.
3
Contract to kill: GNAS mutation.致命契约:GNAS 突变
Mol Cancer. 2025 Mar 7;24(1):70. doi: 10.1186/s12943-025-02247-4.
4
Molecular and immunohistochemical markers in appendiceal mucinous neoplasms: A systematic review and comparative analysis with ovarian mucinous neoplasms and colorectal adenocarcinoma.阑尾黏液性肿瘤中的分子和免疫组化标志物:一项系统综述及与卵巢黏液性肿瘤和结直肠癌的比较分析
Histol Histopathol. 2025 May;40(5):621-633. doi: 10.14670/HH-18-830. Epub 2024 Oct 10.
5
Endoscopic features of the duodenal pyloric gland adenoma: A case series of 14 patients.十二指肠幽门腺腺瘤的内镜特征:14例病例系列
DEN Open. 2024 Nov 19;5(1):e70038. doi: 10.1002/deo2.70038. eCollection 2025 Apr.
6
Gastric epithelial neoplasm of fundic-gland mucosa lineage: representative of the low atypia differentiated gastric tumor and Ki67 may help in their identification.胃底腺黏膜上皮内肿瘤:低异型分化胃肿瘤的代表,Ki67 有助于其识别。
Pathol Oncol Res. 2024 May 30;30:1611734. doi: 10.3389/pore.2024.1611734. eCollection 2024.
7
Decreased expression of TFF2 and decreased αGlcNAc glycosylation are malignant biomarkers of pyloric gland adenoma of the duodenum.TFF2 表达降低和αGlcNAc 糖基化降低是十二指肠幽门腺腺瘤的恶性生物标志物。
Sci Rep. 2023 Dec 8;13(1):21641. doi: 10.1038/s41598-023-49040-1.
8
Genetic analysis of fundic gland‑type gastric adenocarcinoma.胃底腺型胃癌的基因分析
Mol Clin Oncol. 2023 Aug 31;19(4):82. doi: 10.3892/mco.2023.2678. eCollection 2023 Oct.
9
Esophagogastroduodenal Findings in Patients with Intraductal Papillary Mucinous Neoplasms.导管内乳头状黏液性肿瘤患者的食管胃十二指肠检查结果
Diagnostics (Basel). 2023 Jun 20;13(12):2127. doi: 10.3390/diagnostics13122127.
10
Prognostic biomarkers and molecular pathways mediating Helicobacter pylori-induced gastric cancer: a network-biology approach.介导幽门螺杆菌诱发胃癌的预后生物标志物和分子通路:一种网络生物学方法
Genomics Inform. 2023 Mar;21(1):e8. doi: 10.5808/gi.22072. Epub 2023 Mar 31.